Why the study?
Do highly sensitive cardiac troponin assays improve diagnostic accuracy and provide prognostic information in patients with suspected acute coronary syndromes, stable coronary artery disease, and chronic heart failure?
Do highly sensitive cardiac troponin assays improve diagnostic accuracy and provide prognostic information in patients with suspected acute coronary syndromes, stable coronary artery disease, and chronic heart failure?
Answers are grounded in this paper and cite their sources.
Highly sensitive cardiac troponin assays enhance diagnostic and prognostic capabilities across various cardiac conditions, though their reduced specificity highlights the need for serial testing and clinical correlation.
Omland T. (Institute of Clinical Medicine, University of Oslo, Oslo and Division of Medicine, Akershus University Hospital, Lørenskog, Norway) New features of troponin testing in different clinical settings (Review). J Intern Med 2010; 268 : 207–217. Cardiac troponin levels are routinely measured for diagnosing acute myocardial infarction. Cardiac troponin measurements also provide information concerning prognosis and the effect of early intervention in patients with acute coronary syndromes. The recent development of highly sensitive cardiac troponin assays permits detection of very low circulating levels. Use of sensitive troponin assays improves overall diagnostic accuracy in patients with suspected acute coronary syndromes, and these assays provide strong prognostic information in stable coronary artery disease and chronic heart failure. However, increased sensitivity comes with a cost of decreased specificity, and serial testing, as well as clinical context and judgment, is likely to become increasingly important in the interpretation of troponin assay results.
No takes yet. Share an insight, caveat, or question.
Torbjørn Omland (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: